These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition. Singh BK, Sinha RA, Zhou J, Tripathi M, Ohba K, Wang ME, Astapova I, Ghosh S, Hollenberg AN, Gauthier K, Yen PM. J Biol Chem; 2016 Jan 01; 291(1):198-214. PubMed ID: 26453307 [Abstract] [Full Text] [Related]
3. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Hagiwara A, Cornu M, Cybulski N, Polak P, Betz C, Trapani F, Terracciano L, Heim MH, Rüegg MA, Hall MN. Cell Metab; 2012 May 02; 15(5):725-38. PubMed ID: 22521878 [Abstract] [Full Text] [Related]
4. Sirt1 Mediates Vitamin D Deficiency-Driven Gluconeogenesis in the Liver via mTorc2/Akt Signaling. Yuan Q, Zhang R, Sun M, Guo X, Yang J, Bian W, Xie C, Miao D, Mao L. J Diabetes Res; 2022 May 02; 2022():1755563. PubMed ID: 35132380 [Abstract] [Full Text] [Related]
5. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice. Tripathy S, Jump DB. J Lipid Res; 2013 Jan 02; 54(1):71-84. PubMed ID: 23099444 [Abstract] [Full Text] [Related]
6. Rictor, an mTORC2 Protein, Regulates Murine Lymphatic Valve Formation Through the AKT-FOXO1 Signaling. Banerjee R, Knauer LA, Iyer D, Barlow SE, Shalaby H, Dehghan R, Scallan JP, Yang Y. Arterioscler Thromb Vasc Biol; 2024 Sep 02; 44(9):2004-2023. PubMed ID: 39087350 [Abstract] [Full Text] [Related]
7. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Zhang C, Wendel AA, Keogh MR, Harris TE, Chen J, Coleman RA. Proc Natl Acad Sci U S A; 2012 Jan 31; 109(5):1667-72. PubMed ID: 22307628 [Abstract] [Full Text] [Related]
9. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice. Wang Q, Wang N, Dong M, Chen F, Li Z, Chen Y. Clin Sci (Lond); 2014 Jul 31; 127(2):91-100. PubMed ID: 24444370 [Abstract] [Full Text] [Related]
10. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Tang Y, Wallace M, Sanchez-Gurmaches J, Hsiao WY, Li H, Lee PL, Vernia S, Metallo CM, Guertin DA. Nat Commun; 2016 Apr 21; 7():11365. PubMed ID: 27098609 [Abstract] [Full Text] [Related]
11. Neuronal Sirt1 deficiency increases insulin sensitivity in both brain and peripheral tissues. Lu M, Sarruf DA, Li P, Osborn O, Sanchez-Alavez M, Talukdar S, Chen A, Bandyopadhyay G, Xu J, Morinaga H, Dines K, Watkins S, Kaiyala K, Schwartz MW, Olefsky JM. J Biol Chem; 2013 Apr 12; 288(15):10722-35. PubMed ID: 23457303 [Abstract] [Full Text] [Related]
12. Down regulation of Peroxiredoxin-3 in 3T3-L1 adipocytes leads to oxidation of Rictor in the mammalian-target of rapamycin complex 2 (mTORC2). Olson DH, Burrill JS, Kuzmicic J, Hahn WS, Park JM, Kim DH, Bernlohr DA. Biochem Biophys Res Commun; 2017 Nov 25; 493(3):1311-1317. PubMed ID: 28986255 [Abstract] [Full Text] [Related]
13. Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice. Aljaylani A, Fluitt M, Piselli A, Shepard BD, Tiwari S, Ecelbarger CM. Cell Physiol Biochem; 2020 Jul 18; 54(4):682-695. PubMed ID: 32678535 [Abstract] [Full Text] [Related]
14. Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver. Park JM, Kim TH, Bae JS, Kim MY, Kim KS, Ahn YH. Biochem Biophys Res Commun; 2010 Dec 17; 403(3-4):329-34. PubMed ID: 21078299 [Abstract] [Full Text] [Related]
15. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, Chen Q, Li YH, Wang JJ, Kang YM, Zhu GQ. Clin Sci (Lond); 2015 Nov 17; 129(10):839-50. PubMed ID: 26201094 [Abstract] [Full Text] [Related]
16. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis. Lee YS, Lee EK, Oh HH, Choi CS, Kim S, Jun HS. J Diabetes Res; 2014 Nov 17; 2014():961732. PubMed ID: 25610880 [Abstract] [Full Text] [Related]
17. Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling. Zhang D, Tong X, Arthurs B, Guha A, Rui L, Kamath A, Inoki K, Yin L. J Biol Chem; 2014 Sep 12; 289(37):25925-35. PubMed ID: 25063808 [Abstract] [Full Text] [Related]
18. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice. De Souza CT, Frederico MJ, da Luz G, Cintra DE, Ropelle ER, Pauli JR, Velloso LA. J Physiol; 2010 Jun 15; 588(Pt 12):2239-53. PubMed ID: 20421289 [Abstract] [Full Text] [Related]
19. Sestrin 3 protein enhances hepatic insulin sensitivity by direct activation of the mTORC2-Akt signaling. Tao R, Xiong X, Liangpunsakul S, Dong XC. Diabetes; 2015 Apr 15; 64(4):1211-23. PubMed ID: 25377878 [Abstract] [Full Text] [Related]
20. The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells. Bumke-Vogt C, Osterhoff MA, Borchert A, Guzman-Perez V, Sarem Z, Birkenfeld AL, Bähr V, Pfeiffer AF. PLoS One; 2014 Apr 15; 9(8):e104321. PubMed ID: 25136826 [Abstract] [Full Text] [Related] Page: [Next] [New Search]